Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

NCT06391034 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: hyperpolarized pyruvate +/-urea (13C/15N)
RADIATION: Non-investigational External beam radiotherapy (EBRT)
PROCEDURE: Radiotherapy (RT)
PROCEDURE: Multi-parametric magnetic resonance imaging (mpMRI)
BIOLOGICAL: Non-interventional hormone therapy
PROCEDURE: Prostate Biopsy

Sponsor

Robert Bok, MD, PhD

Collaborators

[object Object]